- 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
- 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
- 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
- 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们。
- 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
- 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
重复经颅磁刺激治疗精神分裂症顽固性幻听效果探究
重复经颅磁刺激治疗精神分裂症顽固性幻听效果探究 [摘要] 目的 探究并分析低频重复经颅磁刺激(rTMS)合并利培酮治疗精神分裂症顽固性幻听的疗效及其安全性。 方法 选择2010年12月~2012年12月杭州市第七人民医院住院治疗的精神分裂症患者90例为研究对象。应用随机数字表法将精神分裂症患者分为3组,每组各30例。观察组给予利培酮和rTMS治疗,对照组1给予利培酮和伪rTMS治疗,对照组2则给予维持原治疗剂量利培酮治疗,持续2周时间。在治疗前、治疗2周和治疗后3个月后进行大体评定量表(GAS)、听幻觉量表(AHRS)和副反应量表(TESS)的评定,比较3组患者临床疗效及其安全性。 结果 治疗2周和治疗后3个月对照组1幻听评分高于对照组2,但差异无统计学意义(P 0.05),观察组幻听评分低于对照组2和对照组1,差异有统计学意义(P 0.05)。 结论 1 Hz低频rTMS用于精神分裂症双背侧前额叶能够显著改善精神分裂症患者顽固性幻听症状,具有安全高效等特点。
[关键词] 重复经颅磁刺激;精神分裂症;顽固性幻听;临床疗效
[中图分类号] R749.3 [文献标识码] A [文章编号] 1673-7210(2013)11(a)-0047-04
Effect research on refractory auditory hallucination of schizophrenia by repetitive transcranial magnetic stimulation
TAO Yunhai
Department of First Ward, the Seventh People’s Hospital of Hangzhou City, Zhejiang Province, Hangzhou 310013, China
[Abstract] Objective To explore the effects and its safety of refractory auditory hallucination of schizophrenia by slow repetitive transcranial magnetic stimulation and combined risperidone. Methods 90 schizophrenic patients treated in the Seventh People’s Hospital of Hangzhou City from December 2010 to December 2012 were chosen as the research objects, they were divided into 3 groups with 30 cases in each group. The observation group was given risperidone and rTMS treatment, the control group 1 was given risperidone and pseudo rTMS treatment, the control group 2 was treated with the original dose risperidone treatment, all patients were treated for 2 weeks. Global assessment scale(GAS), auditory hallucination rating scale (AHRS) and treatment emergent symptom scale (TESS) were assessed before treatment, after 2 weeks and 3 months. The effects and its safety of schizophrenia patients were compare. Results The scores of AHRS in the control group 1 were higher than that in the control group 2 after 2 weeks and 3 months, the difference was not statistically significant (P 0.05); the scores of AHRS in observation group were higher than those in other groups after 2 weeks and 3 months, th
原创力文档


文档评论(0)